Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 31–60 of 577 companies · sorted by market cap (high to low)
254 covered companies have no sector on record (3IN.L, AAF.L, AAL.L, ABDN.L, ABF.L, ADM.L, AEP.L, AJB.L, ALFA.L, AML.L, ANTO.L, AO.L), so they were not tested by this filter — a gap in our sector data, not evidence they do not belong here.
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson | Health Care | $184.74 | $50.3B | 55.7 | -2.6% | +7.7% | +1.6% | +22.9% |
| HUM | Humana | Health Care | $401.54 | $48.2B | 38.0 | +18.3% | +0.9% | +0.7% | +28.7% |
| NTRA | Natera | Health Care | $328.18 | $47.3B | n/a | +37.8% | -9.0% | n/a | +97.0% |
| MDLN | Medline Inc. | Health Care | $36.59 | $46.8B | 43.4 | +11.6% | +4.1% | n/a | n/a |
| RVMD | Revolution Medicines | Health Care | $210.02 | $45.0B | n/a | n/a | n/a | n/a | +439.2% |
| IQV | IQVIA | Health Care | $267.77 | $44.7B | 33.2 | +8.2% | +8.3% | n/a | +45.5% |
| VEEV | Veeva Systems | Health Care | $275.09 | $44.5B | 48.7 | +16.3% | +28.4% | n/a | +1.9% |
| A | Agilent Technologies | Health Care | $150.86 | $42.5B | 30.3 | +9.1% | +18.8% | +0.7% | +17.4% |
| IDXX | Idexx Laboratories | Health Care | $535.38 | $42.2B | 37.6 | +12.8% | +24.6% | n/a | -16.4% |
| WAT | Waters Corporation | Health Care | $409.38 | $40.2B | 102.4 | n/a | +20.3% | n/a | +36.6% |
| ALNY | Alnylam Pharmaceuticals | Health Care | $266.11 | $35.6B | 45.3 | +95.1% | +8.4% | n/a | -41.3% |
| DXCM | Dexcom | Health Care | $87.90 | $33.2B | 35.0 | +15.5% | +17.9% | n/a | +8.8% |
| CNC | Centene Corporation | Health Care | $67.04 | $33.1B | n/a | +17.0% | -3.4% | n/a | +134.0% |
| ILMN | Illumina, Inc. | Health Care | $218.22 | $33.0B | 40.6 | +4.9% | +19.6% | n/a | +123.4% |
| RMD | ResMed | | Health Care | $228.35 | $32.9B | 21.9 | +9.8% | +26.9% | +1.2% | -16.6% |
| BIIB | Biogen | Health Care | $220.83 | $32.6B | 39.1 | +0.3% | +13.1% | n/a | +57.8% |
| ZTS | Zoetis | Health Care | $75.81 | $31.3B | 12.5 | +1.4% | +28.2% | +1.6% | -50.5% |
| GEHC | GE HealthCare | Health Care | $68.86 | $31.3B | 15.8 | +6.5% | +10.1% | +0.2% | -7.1% |
| INSM | Insmed | Health Care | $126.29 | $27.6B | n/a | n/a | -210.5% | n/a | -11.4% |
| MTD | Mettler Toledo | Health Care | $1,345.26 | $27.0B | 30.3 | +6.9% | +21.6% | n/a | +4.5% |
| LH | Labcorp | Health Care | $326.89 | $26.5B | 27.0 | +6.4% | +6.3% | +1.4% | +18.8% |
| DGX | Quest Diagnostics | Health Care | $237.14 | $26.2B | 25.1 | +9.9% | +9.0% | +2.1% | +31.7% |
| INCY | Incyte | Health Care | $126.75 | $25.3B | 16.2 | +26.9% | +25.0% | n/a | +48.3% |
| ROIV | Roivant Sciences | Health Care | $34.93 | $25.2B | n/a | -67.6% | -3629.2% | n/a | +177.9% |
| RPRX | Royalty Pharma | Health Care | $63.96 | $24.8B | 43.8 | +10.0% | +32.4% | +3.0% | +73.3% |
| WST | West Pharmaceutical Services | Health Care | $339.97 | $23.9B | 43.5 | +12.4% | +16.1% | +0.3% | +37.3% |
| STE | Steris | Health Care | $224.59 | $21.9B | 28.3 | +8.7% | +13.2% | +1.0% | -7.7% |
| GH | Guardant Health, Inc. | Health Care | $161.41 | $21.7B | n/a | +42.7% | -42.4% | n/a | +163.1% |
| THC | Tenet Healthcare | Health Care | $265.05 | $21.3B | 10.2 | +7.4% | +11.1% | n/a | +37.7% |
| UTHR | United Therapeutics | Health Care | $487.61 | $20.9B | 17.4 | +2.5% | +41.9% | n/a | +28.2% |
Every view here has its own address — copy the link from your browser to share exactly what you are looking at. Click a column header to sort.
Data: SEC EDGAR (filings) + market data (prices, fundamentals). Prices on this page are from the 2026-09-04 close or later — each figure is labelled with its own as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date. Past performance does not indicate future results.